SMAP200900085A - 3-imidazolil-indoli per il trattamento di malattieproliferative - Google Patents

3-imidazolil-indoli per il trattamento di malattieproliferative

Info

Publication number
SMAP200900085A
SMAP200900085A SM200900085T SM200900085T SMAP200900085A SM AP200900085 A SMAP200900085 A SM AP200900085A SM 200900085 T SM200900085 T SM 200900085T SM 200900085 T SM200900085 T SM 200900085T SM AP200900085 A SMAP200900085 A SM AP200900085A
Authority
SM
San Marino
Prior art keywords
malolysiseproliferative
indoles
imidazolyl
treatment
Prior art date
Application number
SM200900085T
Other languages
English (en)
Other versions
SMP200900085B (it
Inventor
Pascal Furet
Andreas Boettcher
Nicole Buschmann
Jean-Marc Groell
Jorg Kallen
Lisztwan Joanna Hergovich
Keiichi Masuya
Lorenz Mayr
Andrea Vaupel
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38328915&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMAP200900085(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SMAP200900085A publication Critical patent/SMAP200900085A/it
Publication of SMP200900085B publication Critical patent/SMP200900085B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
SM200900085T 2007-03-29 2009-10-28 3-imidazolil-indoli per il trattamento di malattieproliferative. SMP200900085B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07105269 2007-03-29
PCT/EP2008/053667 WO2008119741A2 (en) 2007-03-29 2008-03-27 3-imidazolyl-indoles for the treatment of proliferative diseases

Publications (2)

Publication Number Publication Date
SMAP200900085A true SMAP200900085A (it) 2010-01-19
SMP200900085B SMP200900085B (it) 2010-11-12

Family

ID=38328915

Family Applications (1)

Application Number Title Priority Date Filing Date
SM200900085T SMP200900085B (it) 2007-03-29 2009-10-28 3-imidazolil-indoli per il trattamento di malattieproliferative.

Country Status (27)

Country Link
US (1) US8053457B2 (it)
EP (1) EP2142535A2 (it)
JP (1) JP2010522723A (it)
KR (1) KR20090122403A (it)
CN (1) CN101679382A (it)
AR (1) AR065860A1 (it)
AU (1) AU2008234954B9 (it)
BR (1) BRPI0810082A2 (it)
CA (1) CA2682483A1 (it)
CL (1) CL2008000899A1 (it)
CR (1) CR11019A (it)
DO (1) DOP2009000229A (it)
EA (1) EA200901212A1 (it)
EC (1) ECSP099660A (it)
GT (1) GT200900256A (it)
IL (1) IL200862A0 (it)
MA (1) MA31260B1 (it)
MX (1) MX2009010413A (it)
NI (1) NI200900177A (it)
PA (1) PA8774001A1 (it)
PE (1) PE20081897A1 (it)
SM (1) SMP200900085B (it)
TN (1) TN2009000388A1 (it)
TW (1) TW200843746A (it)
UY (1) UY30987A1 (it)
WO (1) WO2008119741A2 (it)
ZA (1) ZA200906210B (it)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101472584B (zh) * 2006-04-07 2013-04-24 詹森药业有限公司 用作组胺h4受体调节剂的吲哚类和苯并咪唑类
AR070398A1 (es) * 2008-02-22 2010-03-31 Gruenenthal Chemie Derivados sustituidos de indol
US20100035862A1 (en) * 2008-06-25 2010-02-11 Abbott Laboratories Novel aza-cyclic indole-2-carboxamides and methods of use thereof
JP6087504B2 (ja) 2008-11-07 2017-03-01 マサチューセッツ インスティテュート オブ テクノロジー アミノアルコールリピドイドおよびその使用
AU2010205201A1 (en) 2009-01-16 2011-08-04 Daiichi Sankyo Company,Limited Imidazothiazole derivative having proline ring structure
JP2012102017A (ja) * 2009-03-03 2012-05-31 Astellas Pharma Inc インドール化合物
WO2010119984A1 (en) * 2009-04-16 2010-10-21 Banyu Pharmaceutical Co.,Ltd. 3-aryl or heteroaryl-substituted indole derivative
CN104876938A (zh) 2009-11-12 2015-09-02 密歇根大学董事会 螺-吲哚酮mdm2拮抗剂
WO2011106650A2 (en) * 2010-02-27 2011-09-01 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Novel p53-mdm2/p53-mdm4 antagonists to treat proliferative disease
JO2998B1 (ar) * 2010-06-04 2016-09-05 Amgen Inc مشتقات بيبيريدينون كمثبطات mdm2 لعلاج السرطان
AU2011299551A1 (en) 2010-09-08 2013-03-21 University Of Pittsburgh - Of The Commonwealth System Of Higher Education P53-Mdm2 antagonists
FR2967072B1 (fr) 2010-11-05 2013-03-29 Univ Dundee Procede pour ameliorer la production de virus et semences vaccinales influenza
UY33725A (es) 2010-11-12 2012-06-29 Sanofi Sa Antagonistas de mdm2 de espiro-oxindol
US20120202794A1 (en) * 2011-01-24 2012-08-09 Pharmasset, Inc. Compounds
SG193002A1 (en) 2011-03-10 2013-09-30 Daiichi Sankyo Co Ltd Dispiropyrrolidine derivative
CN102702066A (zh) * 2011-03-28 2012-10-03 苏州百灵威超精细材料有限公司 一种用于合成抗癌和减肥药物中间体6-氯-5-氟吲哚的制备新方法
PL2691443T3 (pl) 2011-03-28 2021-08-30 Massachusetts Institute Of Technology Sprzężone lipomery i ich zastosowania
EP2707372B1 (en) 2011-05-11 2016-12-21 The Regents Of The University Of Michigan Spiro-oxindole mdm2 antagonists
US20140189897A1 (en) 2011-06-21 2014-07-03 Mayo Foundation For Medical Education And Research Transgenic animals capable of being induced to delete senescent cells
WO2012176123A1 (en) * 2011-06-22 2012-12-27 Novartis Ag 3 - imidazolyl- indoles for the treatment of proliferative diseases
US9408885B2 (en) 2011-12-01 2016-08-09 Vib Vzw Combinations of therapeutic agents for treating melanoma
WO2013090645A1 (en) 2011-12-13 2013-06-20 Buck Institute For Research On Aging Methods for improving medical therapies
WO2013158664A2 (en) 2012-04-17 2013-10-24 Kythera Biopharmaceuticals, Inc. Use of engineered viruses to specifically kill senescent cells
WO2014028487A1 (en) 2012-08-13 2014-02-20 Massachusetts Institute Of Technology Amine-containing lipidoids and uses thereof
US9901080B2 (en) 2012-08-23 2018-02-27 Buck Institute For Research On Aging Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells
US9901081B2 (en) 2012-08-23 2018-02-27 Buck Institute For Research On Aging Transgenic mouse for determining the role of senescent cells in cancer
TWI586668B (zh) 2012-09-06 2017-06-11 第一三共股份有限公司 二螺吡咯啶衍生物之結晶
RU2690663C2 (ru) 2012-12-20 2019-06-05 Мерк Шарп И Доум Корп. Замещенные имидазопиридины в качестве ингибиторов hdm2
US9315472B2 (en) 2013-05-01 2016-04-19 Massachusetts Institute Of Technology 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
US20170216286A1 (en) 2014-01-28 2017-08-03 Mayo Foundation For Medical Education And Research Killing senescent cells and treating senescence-associated conditions using a src inhibitor and a flavonoid
MX2016009753A (es) 2014-01-28 2017-07-07 Buck Inst For Res On Aging Metodos y composiciones para exterminar celulas senescentes y para tratar enfermedades y trastornos asociados con la senectud.
EP3708170A1 (en) 2014-05-05 2020-09-16 BioVentures, LLC Compositions and methods for inhibiting antiapoptotic bcl-2 proteins as anti-aging agents
WO2016004202A1 (en) 2014-07-02 2016-01-07 Massachusetts Institute Of Technology Polyamine-fatty acid derived lipidoids and uses thereof
US10576064B2 (en) 2014-07-03 2020-03-03 Boehringer Ingelheim International Gmbh Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
AU2015292710A1 (en) 2014-07-22 2017-02-16 Bioventures, Llc. Compositions and methods for selectively depleting senescent cells
EP3242867A4 (en) 2014-12-26 2018-11-07 Dow Global Technologies LLC Organic compounds and electronic device comprising organic layer comprising organic compounds
TWI711452B (zh) 2015-02-20 2020-12-01 日商第一三共股份有限公司 癌症的倂用治療法
JP6823587B2 (ja) 2015-04-13 2021-02-03 第一三共株式会社 Ｍｄｍ２阻害剤とｂｔｋ阻害剤との併用治療法
MX2017017172A (es) * 2015-06-22 2018-02-23 Bayer Pharma AG Conjugados de ligador-principio activo (adcs) y conjugados de ligador-profarmaco (apdcs) con grupos enzimaticamente escindibles.
JOP20160198B1 (ar) * 2015-09-16 2022-03-14 Janssen Pharmaceuticals Inc مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
LT3359542T (lt) 2015-10-09 2021-05-25 Boehringer Ingelheim International Gmbh Spiro[3h-indolo-3,2 -pirolidin]-2(1h)-ono junginiai ir dariniai, kaip mdm2-p53 inhibitoriai
US10759808B2 (en) 2016-04-06 2020-09-01 The Regents Of The University Of Michigan Monofunctional intermediates for ligand-dependent target protein degradation
RU2743432C2 (ru) 2016-04-06 2021-02-18 Дзе Риджентс Оф Дзе Юниверсити Оф Мичиган Деструкторы белка mdm2
KR102447884B1 (ko) 2016-04-21 2022-09-27 바이오벤처스, 엘엘씨 항-세포자멸적 bcl-2 계열 단백질의 열화를 유도하는 화합물 및 이의 용도
CN105906610B (zh) * 2016-05-24 2018-10-23 绍兴文理学院 一种3-（4-苯基-1h-咪唑-5-基）-1h-吲哚衍生物及其制备方法和应用
PT3272745T (pt) * 2016-07-21 2019-09-27 Inst Farmakologii Polskiej Akademii Nauk Derivados de indol substituídos com imidazolilo que se ligam ao recetor de serotonina 5-ht7 e composições farmacêuticas dos mesmos
US20190240210A1 (en) 2016-10-17 2019-08-08 Daiichi Sankyo Company, Limited Treatment Method by Combined Use of MDM2 Inhibitor and DNA Methyltransferase Inhibitor
WO2018096159A1 (en) * 2016-11-28 2018-05-31 F. Hoffmann-La Roche Ag Oxadiazolones as transient receptor potential channel inhibitors
WO2018114578A1 (de) 2016-12-21 2018-06-28 Bayer Pharma Aktiengesellschaft Binder-wirkstoff-konjugate (adcs) mit enzymatisch spaltbaren gruppen
JP7178357B2 (ja) 2017-03-07 2022-11-25 エフ．ホフマン－ラ ロシュ アーゲー オキサジアゾール一過性受容器電位チャネル阻害剤
MX2019011945A (es) 2017-04-05 2019-11-28 Boehringer Ingelheim Int Terapia de combinacion contra cancer.
JOP20190245A1 (ar) 2017-04-20 2019-10-15 Novartis Ag أنظمة توصيل إطلاق مستدام تتضمن روابط بلا أثر لنقطة الربط
EP3630109A4 (en) * 2017-05-26 2021-03-17 Rutgers, the State University of New Jersey BACTERIAL DRAIN PUMP INHIBITORS
US10710994B2 (en) 2018-03-19 2020-07-14 Genentech, Inc. Oxadiazole transient receptor potential channel inhibitors
TW202027794A (zh) 2018-10-03 2020-08-01 瑞士商諾華公司 血管生成素樣３多肽之持續遞送
JP2024502258A (ja) * 2020-12-22 2024-01-18 ノバルティス アーゲー Ｃｇａｓに関連する状態の処置に有用なインドール誘導体
WO2022204235A1 (en) * 2021-03-23 2022-09-29 Nido Biosciences, Inc. Bicyclic compounds as androgen receptor modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19948417A1 (de) 1999-10-07 2001-04-19 Morphochem Ag Imidazol-Derivate und ihre Verwendung als Arzneimittel
JP2002114780A (ja) * 2000-10-11 2002-04-16 Taisho Pharmaceut Co Ltd ４−（３−インドリル）イミダゾール誘導体
CA2598690C (en) 2005-02-22 2011-11-15 The Regents Of The University Of Michigan Small molecule inhibitors of mdm2 and uses thereof
US7576082B2 (en) 2005-06-24 2009-08-18 Hoffman-La Roche Inc. Oxindole derivatives

Also Published As

Publication number Publication date
PA8774001A1 (es) 2008-11-19
MX2009010413A (es) 2009-10-20
AU2008234954A1 (en) 2008-10-09
UY30987A1 (es) 2008-10-31
GT200900256A (es) 2010-03-15
TW200843746A (en) 2008-11-16
US8053457B2 (en) 2011-11-08
MA31260B1 (fr) 2010-03-01
EP2142535A2 (en) 2010-01-13
EA200901212A1 (ru) 2010-04-30
KR20090122403A (ko) 2009-11-27
CL2008000899A1 (es) 2009-02-20
SMP200900085B (it) 2010-11-12
WO2008119741A3 (en) 2008-12-04
WO2008119741A2 (en) 2008-10-09
AR065860A1 (es) 2009-07-08
ZA200906210B (en) 2010-05-26
AU2008234954B9 (en) 2012-02-02
NI200900177A (es) 2010-09-09
AU2008234954B2 (en) 2011-10-27
CN101679382A (zh) 2010-03-24
CR11019A (es) 2009-10-20
IL200862A0 (en) 2010-05-17
US20100125064A1 (en) 2010-05-20
DOP2009000229A (es) 2009-10-31
ECSP099660A (es) 2009-10-30
BRPI0810082A2 (pt) 2014-10-21
PE20081897A1 (es) 2009-02-09
JP2010522723A (ja) 2010-07-08
CA2682483A1 (en) 2008-10-09
TN2009000388A1 (en) 2010-12-31

Similar Documents

Publication Publication Date Title
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
DK3289876T3 (da) Forbindelser til behandling af cancer
DK2121139T3 (da) Formulations for cancer treatment
BRPI0813670A2 (pt) Compostos para tratamento
DK2330887T3 (da) Behandlingsindretning
DK2173831T3 (da) Brøndbehandling
ZA201006752B (en) Spiro-indole derivatives for the treatment of parasitic disease
BRPI0820410A2 (pt) Lactans substituídos terapêuticos
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
BRPI0818598A2 (pt) agentes terapêuticos - 802
ITMI20061848A1 (it) Procedimento per la preparazione di composti feniltetrazolici
BRPI0909764A2 (pt) compostos terapêuticos
ITRM20080037A1 (it) Procedimento per la ultrapurificazione di alginati.
BRPI0906879A2 (pt) Compostos terapêuticos
BRPI0812105A2 (pt) Neramexano para o tratamento de nistagmo
IT1391776B1 (it) Procedimento per la preparazione di dexlansoprazolo
ITMI20060489A1 (it) Procedimento per la preparazione di 1-beono-3-trifluorometossibenzene
ITMI20060760A1 (it) Procedimento per il trattamento di tessuti
ITMI20080223A1 (it) Apparato per l'applicazione di trattamenti di ipertermia
TH99984B (th) อ่างล้างหน้า
DK2257548T3 (da) Terapeutiske forbindelser
IT1391758B1 (it) Procedimento per la preparazione di dexlansoprazolo amorfo
ES1066260Y (es) Bañera
TH102199B (th) อ่างอาบน้ำ